医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Mazor Robotics Announces First Renaissance™ System Order from Japanese Distributor Adachi Medical Instruments Co.

2012年10月22日 PM10:55
このエントリーをはてなブックマークに追加


 

CAESAREA, Israel

Mazor Robotics Ltd. (TASE:MZOR), a developer of innovative surgical robots and complementary products, today announced that Adachi Medical Instruments Co., Mazor’s distribution partner in Japan, placed an order for its Renaissance™ system. As part of the distribution agreement, Adachi is committed to obtain Japanese PMDA (Pharmaceuticals and Medical Devices Agency) approval for the Renaissance system. The system purchased will be used to facilitate the PMDA process

Japan represents the second largest healthcare market in the world, and its spine market is estimated to be over $400 million with a significant trend towards surgeons performing minimally invasive procedures. It is projected that by 2020, nearly 50% of Japan’s population will be over the age of 50, driving the need for improved spinal implant technology.

“We are delighted to partner with Mazor to deliver their innovative products to the Japanese market,” commented Saburo Adachi, President of Adachi. “We believe strongly in the strength of a mutually beneficial partnership and look forward to working together with Mazor to meet the requirements of the Japanese government to obtain the necessary approvals and deliver this advanced technology to Japan.”

“The distribution agreement and initial purchase order from Adachi signifies an important step in expanding the market for Renaissance in Asia,” said Ori Hadomi, Chief Executive Officer of Mazor. “Adachi is an 80 year-old family-owned business that has established relationships with leading hospitals and medical organizations. It has significant experience in distributing leading medical technology and clearing the regulatory hurdles. We’re so pleased to enter the Japanese market with Adachi as our partner.”

Renaissance, Mazor Robotics’ next generation surgical guidance system for spine procedures, is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art procedures, with less radiation – even for minimally invasive surgery, scoliosis, and other complex spinal deformity cases. It is the only robotic technology for spine surgery available in the marketplace.

About Mazor

Mazor Robotics (TASE:MZOR) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 20,000 implants in the United States and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, please visit www.mazorrobotics.com.

CONTACT

EVC Group
Aimee Gordon, 646-445-4800 (Investors)
agordon@evcgroup.com
Robert
Jones, 646-445-4800 (Investors)
bjones@evcgroup.com
Chris
Gale, 646-201-5431 (Media)
cgale@evcgroup.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Kaplan Test Prep and CBLA Collaborate to Publish First Official OET Study Guide
  • Analytics 4 Life®的医学顾问委员会新增全球心内科专家
  • BRIC HOLDING Offers Aimedis – ICO: Germany’s Leading eHealth Platform Goes Public
  • Research Paper Co-authored by Dr. Damien Bates, Chief Medical Officer and Head of Medical Research at SanBio Group, Published in Stroke
  • Clinigen signs agreement with Nordic Pharma for aprotinin